These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Ma WL; Hsu CL; Wu MH; Wu CT; Wu CC; Lai JJ; Jou YS; Chen CW; Yeh S; Chang C Gastroenterology; 2008 Sep; 135(3):947-55, 955.e1-5. PubMed ID: 18639551 [TBL] [Abstract][Full Text] [Related]
8. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Shafi AA; Yen AE; Weigel NL Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952 [TBL] [Abstract][Full Text] [Related]
9. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma]. Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Hepatocellular Carcinoma in Men and the Contribution of Androgen and its Receptor in Pathogenesis and Therapy. Abdel-Hamid NM; Al-Quzweny RM Curr Mol Pharmacol; 2023; 16(5):559-563. PubMed ID: 36221879 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Wu MH; Ma WL; Hsu CL; Chen YL; Ou JH; Ryan CK; Hung YC; Yeh S; Chang C Sci Transl Med; 2010 May; 2(32):32ra35. PubMed ID: 20484730 [TBL] [Abstract][Full Text] [Related]
12. Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma. Jiang L; Shan J; Shen J; Wang Y; Yan P; Liu L; Zhao W; Xu Y; Zhu W; Su L; Chen J; Cheng F; Yao H; Xu H; Qian C; Liang Z Oncotarget; 2016 Jun; 7(24):36814-36828. PubMed ID: 27167111 [TBL] [Abstract][Full Text] [Related]
13. Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Ao J; Meng J; Zhu L; Nie H; Yang C; Li J; Gu J; Lin Q; Long W; Dong X; Li C Mol Oncol; 2012 Oct; 6(5):507-15. PubMed ID: 22819717 [TBL] [Abstract][Full Text] [Related]
14. MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis. Tsai YW; Jeng KS; He MK; Hsieh YW; Lai HH; Lai CY; Huang CC; Chang CF; Huang CT; Her GM Cells; 2021 Dec; 10(12):. PubMed ID: 34943942 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. Charrez B; Qiao L; Hebbard L World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137 [TBL] [Abstract][Full Text] [Related]
16. HBx-induced androgen receptor expression in HBV-associated hepatocarcinoma is independent of the methylation status of its promoter. Zhu R; Zhang JS; Zhu YZ; Fan J; Mao Y; Chen Q; Zhu HG Histol Histopathol; 2011 Jan; 26(1):23-35. PubMed ID: 21117024 [TBL] [Abstract][Full Text] [Related]
17. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype. Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma. Jiang G; Shi L; Zheng X; Zhang X; Wu K; Liu B; Yan P; Liang X; Yu T; Wang Y; Cai X Aging (Albany NY); 2020 Jun; 12(12):11466-11484. PubMed ID: 32579541 [TBL] [Abstract][Full Text] [Related]
20. Liver-specific androgen receptor knockout attenuates early liver tumor development in zebrafish. Li H; Li Y; Lu JW; Huo X; Gong Z Sci Rep; 2019 Jul; 9(1):10645. PubMed ID: 31337771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]